NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $313,358 | -27.4% | 19,403 | +86.6% | 0.00% | -20.0% |
Q2 2023 | $431,600 | -20.3% | 10,400 | +15.6% | 0.01% | -16.7% |
Q1 2023 | $541,260 | -95.5% | 9,000 | -94.5% | 0.01% | -95.2% |
Q4 2022 | $12,058,739 | +11.0% | 164,400 | +15.0% | 0.12% | +6.8% |
Q3 2022 | $10,865,000 | +10.6% | 143,000 | +1.1% | 0.12% | +19.4% |
Q2 2022 | $9,827,000 | -45.0% | 141,400 | -34.4% | 0.10% | -43.7% |
Q1 2022 | $17,862,000 | +8831.0% | 215,600 | +11891.1% | 0.17% | +8600.0% |
Q3 2020 | $200,000 | +1011.1% | 1,798 | +491.4% | 0.00% | – |
Q2 2020 | $18,000 | -94.2% | 304 | -93.4% | 0.00% | -100.0% |
Q1 2020 | $308,000 | -80.3% | 4,580 | -90.8% | 0.00% | -80.0% |
Q2 2018 | $1,565,000 | +43.6% | 50,000 | 0.0% | 0.02% | +42.9% |
Q1 2018 | $1,090,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |